Molecular imaging spoils mystery of listeriosis

Article

With the help of molecular imaging, Stanford University biochemist Jonathan Hardy, Ph.D., has added a new chapter to the mystery of listeriosis, a sometimes fatal bacterial infection linked to unpasteurized cheese.

With the help of molecular imaging, Stanford University biochemist Jonathan Hardy, Ph.D., has added a new chapter to the mystery of listeriosis, a sometimes fatal bacterial infection linked to unpasteurized cheese.

As anyone in France knows, pasteurization ruins the flavor of the 500 varieties of cheese manufactured there. The government accepts as a matter of course that a few French people will die every year after eating cheese infected with Listeria, the bacterial cause of listeriosis. (The USDA requires pasteurization for this reason.)

The Pasteur Institute has studied the bacterium for more than 70 years without definitively identifying which organ serves as its central point of habitation. Using recombinant gene technology, Hardy and colleagues introduced the gene for firefly luciferase into the DNA of the bacterium to allow noninvasive tracking with bioluminescent optical imaging in mice. He reportedly had no trouble persuading the mice to eat the subject of his investigation.

Hardy found that Listeria does its deadly work from the gallbladder, whose toxic bile contents were thought to kill bacteria. He presented the study at the 2005 Society of Molecular Imaging meeting in Cologne, Germany.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.